Program

84
25
4
3
1
1
1

Journal Year Published

7
11
17
12
19
13
8
7
8
2
1

Author

105
201
181
149
139
133
133
125
123
108
95
82
78
63
62
54
50
46
43
43

Category

57
31
27
7
4
2
1
1
1

Keyword

38
21
15
12
12
10
10
8
7
7
7
7
6
6
5
5
5
5
5
5

Journal

9
8
6
6
6
5
3
3
3
2
2
2
2
2
2
2
2
1
1
1

NCATS Publications

Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.


Frankowski KJ, et al.


Sci Transl Med , (10), 2018.

Article Pubmed

Sample image from publication page

A modified gene trap approach for improved high-throughput cancer drug discovery.


Morris SM, Mhyre AJ, Carmack SS, Myers CH, Burns C, Ye W, Ferrer-Alegre M, Olson JM, Klinghoffer RA


Oncogene , 2018.

Article Pubmed

Sample image from publication page

Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma.


McKinnon T, Venier R, Yohe M, Sindiri S, Gryder BE, Shern JF, Kabaroff L, Dickson B, Schleicher K, Chouinard-Pelletier G, Menezes S, Gupta A, Zhang X, Guha R, Ferrer-Alegre M, Thomas C, Wei Y, Davani D, Guidos CJ, Khan J, Gladdy RA


Oncogene , 2018.

Article Pubmed

Inhibition of PIP4Kγ ameliorates the pathological effects of mutant huntingtin protein.


Al-Ramahi I, Panapakkam Giridharan SS, Chen YC, Patnaik S, Safren N, Hasegawa J, de Haro M, Wagner Gee AK, Titus SA, Jeong H, Clarke J, Krainc D, Zheng W, Irvine RF, Barmada S, Ferrer-Alegre M, Southall N, Weisman LS, Botas J, Marugan JJ


Elife , (6), 2017.

Article Pubmed

Sample image from publication page

Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.


Heske CM, Davis MI, Baumgart JT, Wilson K, Gormally MV, Chen L, Zhang X, Ceribelli M, Duveau D, Guha R, Ferrer-Alegre M, Arnaldez FI, Ji J, Tran HL, Zhang Y, Mendoza A, Helman LJ, Thomas C


Clin. Cancer Res. , 2017.

Article Pubmed

Sample image from publication page

Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells.


Datta A, Kim H, Lal M, McGee L, Johnson A, Moustafa AA, Jones JC, Mondal D, Ferrer-Alegre M, Abdel-Mageed AB


Cancer Lett. , (408), 73-81, 2017.

Article Pubmed

Sample image from publication page

Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.


He S, Li K, Lin B, Hu Z, Xiao J, Hu X, Wang A, Xu X, Ferrer-Alegre M, Southall N, Zheng W, Aubé J, Schoenen FJ, Marugan J, Liang TJ, Frankowski KJ


J. Med. Chem. , (60), 6364-6383, 2017.

Article Pubmed

Sample image from publication page